Per Dr. Chandler Marrs (who runs www.hormonesmatter.com), “Above and around genetic codes reside the on/off switches to many processes (the switching of genes on and off is epigenetics). If common medications, including fluoroquinolones, up or downregulate these processes and create new diseases, what is someone who takes them supposed to do? Can epigenetic changes be reversed? What is the patient to do with all the recent research on epigenetics? The research is all well and good, but what does it mean to the patient?”
Here is a post about how fluoroquinolones, and other common pharmaceuticals, affect epigenetics. There are currently more questions than answers and the right path is far from clear.
Tagged: ciprofloxacin, drugs and epigenetics, epigenetic research, epigenetics, epigenetics and disease, fluoroquinolones, gene expression, levofloxacin, medications, moxifloxacin, pharmaceuticals and epigenetics, topoisomerase interrupters